Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193156 | SCV000247178 | uncertain significance | not specified | 2015-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705079 | SCV000569111 | likely benign | not provided | 2020-08-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000707283 | SCV000836373 | uncertain significance | Hereditary spastic paraplegia 54 | 2025-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with tyrosine, which is neutral and polar, at codon 76 of the DDHD2 protein (p.Gly76Tyr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DDHD2-related conditions. ClinVar contains an entry for this variant (Variation ID: 210840). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |